Guanosine monophosphate
|
Basic information |
| Metabolite name | Guanosine monophosphate |
 | HMDB0001397 |
 |
C00144 |
 |
6804 |
| Synonyms | Guanosine 5'-phosphate; |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | Guanosine monophosphate |
| HMDB0001397 |
|
C00144 |
|
6804 |
| Synonyms | Guanosine 5'-phosphate; |
| No. of studies | 10 |
|
Relationship between Guanosine monophosphate and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Intestine | Cynomolgus monkey | Up |
| Study M664 | Type2 | CSDS + Dl-3-n-butylphthalide group vs. CSDS group | Hippocampus | C57BL/6 J mouse | Up |
| Study M712 | Type1 | depression group vs. control group | Intestine | Cynomolgus monkey | Up |
| Study M839 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M863 | Type2 | CSDS+ edaravone group vs. CSDS group | Medial prefrontal cortex | C57BL/6J mouse | Up |
| Study M863 | Type2 | CSDS+ edaravone group vs. CSDS group | Hippocampus | C57BL/6J mouse | Up |
| Study M885 | Type1 | CMS-vulnerable group vs. control group | Ventral hippocampus | Wistar rat | Up |
| Study M894 | Type2 | electromagnetic field exposure + heat acclimation group vs. electromagnetic field exposure group | Serum | C57BL/6J mouse | Down |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M940 | Type1 | CUMS group vs. control group | Cerebral cortex | Sprague-Dawley rat | Down |